Artiva’s AlloNK Study for Refractory Rheumatoid Arthritis

Artiva's AlloNK® Study for refractory rheumatoid arthritis aims to understand whether an investigational natural killer (NK) cell therapy can help reduce your rheumatoid arthritis symptoms.

Osteogenesis Imperfecta (OI) | Clinical Study

A clinical study for children and adolescents with osteogenesis imperfecta (OI). If your child or a loved one has OI, they may be eligible for this study, which is evaluating if an investigational medication, romosozumab, may be a potential therapy for osteogenesis imperfecta.

SENTRY-CD19 | Leukemia and Lymphoma Clinical Study

If you or a loved one has leukemia or lymphoma, learn more about this opportunity to participate in a clinical study evaluating a one-time investigational gene therapy that may help your immune system fight cancer more effectively.

Artiva’s AlloNK Study for Scleroderma

Artiva's AlloNK® Study for scleroderma aims to understand whether an investigational natural killer (NK) cell therapy can help reduce your scleroderma symptoms.

Sjögren’s Clinical Study

If you have Sjögren’s, you may be eligible to participate in a clinical study looking to help relieve symptoms related to Sjögren’s and evaluate changes in your quality of life.

ZuraBio | TibuSURE | Systemic Sclerosis Study

If you or a loved one are living with systemic sclerosis (scleroderma or SSc), consider joining the TibuSURE clinical study where researchers are exploring whether a new study drug could impact disease progression in individuals with systemic sclerosis.

Artiva’s AlloNK Study for Sjögren’s

Artiva's AlloNK® Study for Sjögren’s aims to reduce inflammation and symptoms of Sjögren’s.

Interstitial Cystitis/Bladder Pain Syndrome Clinical Study

Is pelvic pain an issue for you? You may be eligible to participate in a clinical trial for an alternative treatment.

X-TOLE and X-ACKT | Epilepsy Studies

For those living with either focal-onset seizures (FOS) or primary generalized tonic-clonic seizures (PGTCS), you may be eligible for a clinical trial that may help reduce the frequency of seizures.

Artiva’s AlloNK Study for Myositis

Artiva's AlloNK® Study for myositis aims to reduce inflammation and symptoms of Polymyositis (PM),Dermatomyositis (DM), or Inclusion Body Myositis (IBM).